RxDoctor Payments Data

Eric Whittington, MD

Vascular Surgery · Madison, WINPI 1053792457

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,670 of the $6,397 with a category attached, or 73.0%. 26 manufacturers reported payments, led by Medtronic at 32.2% of the total. Reporting peaked in 2022 at $2,154 and has fallen 55.4% since, to $961 in 2025.

$6,397in general payments, 2019–2025

Across 80 payments — averaging $79.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Silk Road Medical, Inc.$970
  • W. L. Gore & Associates, Inc.$814
  • Surmodics, Inc.$489
  • Penumbra, Inc.$400
  • Boston Scientific$242
  • plus $1K from 20 others

What the payments were for

  • Grants$1,05717%
  • Travel & lodging$3525%
  • Food & beverage$4,67073%
  • Education$3185%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,397 in reported general payments places this provider in the 75th percentile of 81 vascular surgery providers in Wisconsin.

See all vascular surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$57,085
Medicare patients
278
Services billed
516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban39$26,563
ClopidogrelClopidogrel Bisulfate28$237
Atorvastatin Calcium29$216
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$153

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →